1. Home
  2. CQP vs BNTX Comparison

CQP vs BNTX Comparison

Compare CQP & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheniere Energy Partners LP

CQP

Cheniere Energy Partners LP

HOLD

Current Price

$64.29

Market Cap

28.9B

Sector

Utilities

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$91.20

Market Cap

25.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CQP
BNTX
Founded
2003
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9B
25.5B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
CQP
BNTX
Price
$64.29
$91.20
Analyst Decision
Sell
Strong Buy
Analyst Count
7
13
Target Price
$55.86
$134.15
AVG Volume (30 Days)
90.0K
1.1M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
5.20%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$10,758,000,000.00
N/A
Revenue This Year
$2.21
N/A
Revenue Next Year
$2.31
$2.61
P/E Ratio
$916.14
N/A
Revenue Growth
23.60
N/A
52 Week Low
$49.53
$79.81
52 Week High
$68.42
$124.00

Technical Indicators

Market Signals
Indicator
CQP
BNTX
Relative Strength Index (RSI) 70.40 35.49
Support Level $52.09 N/A
Resistance Level N/A $112.30
Average True Range (ATR) 1.66 3.29
MACD 0.12 -1.97
Stochastic Oscillator 77.33 34.40

Price Performance

Historical Comparison
CQP
BNTX

About CQP Cheniere Energy Partners LP

Cheniere Energy Partners is a liquified natural gas producer operating one facility in Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. The profit generated through those activities is split with parent and operator Cheniere Energy.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: